Entrada Therapeutics Grants 12,990 RSUs to Newly Hired Employees Under 2025 Inducement Plan
Reuters
Mar 03
Entrada <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Grants 12,990 RSUs to Newly Hired Employees Under 2025 Inducement Plan
Entrada Therapeutics granted an aggregate 12,990 restricted stock units to two newly hired non-executive employees under its 2025 Inducement Equity Plan, effective March 1, 2026. One-fourth of the RSUs vest on the one-year anniversary of the vesting start date, with 6.25% vesting quarterly thereafter on March 1, June 1, September 1 and December 1, subject to continued service.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Entrada Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202603021630PRIMZONEFULLFEED9663213) on March 02, 2026, and is solely responsible for the information contained therein.
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.